Martin Shkreli's complaint leads to FTC drug price settlement

Martin Shkreli . . . whistleblower? The Federal Trade Commission, following an exclusive report by The Post, has settled charges against UK-based drug maker Mallinckrodt for allegedly creating a monopoly to jack up the price of a drug used to treat infant spasms by 85,000 percent since 2001, to $34,000 a vial. The twist: the...